Olema Pharmaceuticals, Inc.·4

Jun 23, 5:25 PM ET

Larson Yi 4

Research Summary

AI-generated summary

Updated

Olema (OLMA) Director Larson Yi Receives Stock Award

What Happened

  • Director Larson Yi received a grant/award reported as a derivative covering 29,500 shares on June 18, 2026. The filing lists an acquisition price of $0.00 and a reported total value of $0.00 for the transaction. This was an award (not an open-market purchase or sale).

Key Details

  • Transaction date: 2026-06-18; Report filed: 2026-06-23 (filed late — transactionTimeliness = 'L').
  • Reported terms: 29,500 shares acquired as a derivative instrument, price reported $0.00, total reported value $0.00.
  • Vesting: Shares subject to the option vest in 12 equal monthly installments starting June 18, 2026; any unvested portion vests in full on the issuer's next annual meeting if not fully vested earlier (subject to continued service). (Footnote F1)
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Type of transaction code: A (Grant/Award/Other Acquisition); not an exercise or sale.

Context

  • This was a grant of a derivative award (an option-type award per the footnote), not a cash purchase or sale. There was no immediate exercise or sale reported. For retail investors, grants indicate company compensation to insiders but do not necessarily signal buying or selling intent; the vesting schedule ties value realization to continued service and/or the next annual meeting.